Gait Profile Score in Children With Cerebral Palsy (CP): Influence of the CP Type, Treatment With Botulinum Injection and Multilevel Surgery
Key facts
- Who runs it
- Centre Hospitalier Universitaire de Saint Etienne
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 51 people enrolled
- Started
- 6 Mar 2024
- Ended
- 30 Sept 2024
- Type of study
- Observational
- Treatments tested
- Gait Profile Score
- Gait Visual Score
- Record updated
- 10 January 2025
Who can take part
- Age
- 6 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Etiology of cerebral palsy
- Unilateral, bilateral, triplegic or quadriplegic forms of cerebral palsy
- 6 to 18 years old
- GMFCS (Gross Motor Function Classification System) I to III
- Instrumented gait analysis of the laboratory of St-Etienne
- Absence of botulinum toxin injection or serial casting in the three months after a first instrumented gait analysis
Who cannot take part
- Previous surgery in lower-limb
- Etiology others than cerebral palsy as defined classically (ex: ischemic infarcts in a child older than two years)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Instrumented three dimensional gait analysis (3DGA) permits to record spatial, temporal, kinetics, kinematics and electromyographic (EMG) parameters in order to understand gait impairment in children and teenagers with cerebral palsy (CP). Nowadays, single-event multilevel surgery in subjects with CP cannot be performed without 3DGA. However, interpretation of multiple and interdependent data remains complex for the clinician. To address this issue, gait statistical index have been developed to give a single measure of the quality of the gait pattern. Among actual index, the Gait Profile Score (GPS), developed by Baker et al (2009), measure the deviation of kinematics parameters from a controlled dataset. The GPS can be divided in nine Gait Variable Score (GVS), corresponding to major lower limb joints: the MAP (Movement Analysis Profile). Many studies have reported the interest of the GPS to analysis gait of subjects with CP: good inter-session reliability, predictor of postoperative kinematic improvement, minimal clinical threshold calculated at 1.6°, significant relationship with clinical data (joint contractures), and sensibility to change after a single-event multilevel surgery.
The group in the trial
- EXPERIMENTAL GROUP
Children and teenagers with CP with an instrumented gait analysis performed since 2019.
Treatment: Gait Profile Score and Gait Visual Score
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 10 January 2025